Treatment of nonatypical and atypical endometrial hyperplasia with a levonorgestrel-releasing intrauterine system
- PMID: 12748501
- DOI: 10.1067/mob.2003.346
Treatment of nonatypical and atypical endometrial hyperplasia with a levonorgestrel-releasing intrauterine system
Abstract
Objective: A "frameless" intrauterine drug delivery system that releases 14 microg/d of levonorgestrel was used to treat nonatypical and atypical endometrial hyperplasia in 12 women.
Study design: This noncomparative study had up to 3 to 4 years of follow-up.
Results: The cure rate was 100%, as confirmed by repeat endometrial biopsy.
Conclusion: This method could be considered an alternative to hysterectomy.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
